Is ApoB more useful than LDL cholesterol for understanding heart disease risk?

LDL cholesterol measures the amount of cholesterol carried inside LDL particles. ApoB provides an estimate of the number of circulating atherogenic particles because each carries one ApoB molecule. Two people can therefore have similar LDL cholesterol but different particle burdens. When particles carry less cholesterol individually, LDL can look relatively reassuring while ApoB remains elevated. In large cohort analyses, ApoB adds risk information when conventional lipid measures disagree, making it particularly useful for clarifying an apparently good LDL result.[1][2]

This does not make the rest of the lipid panel obsolete. LDL cholesterol and non-HDL cholesterol remain useful treatment measures, triglycerides provide metabolic context, and lipoprotein(a) identifies a distinct inherited component of risk. ApoB also does not measure existing plaque or replace blood pressure, smoking history, diabetes assessment and family history. The practical benefit is a clearer estimate of particle exposure, especially when results are discordant, rather than a new number that guarantees cardiovascular safety on its own.[2][3]